Want to continue viewing company data?

Sign up for exclusive competitive intelligence.
Company Data Subscription $329 per month (billed Annually)
Signup to View Free Sample

Natera Inc (Natera), formerly Gene Security Network LLC, develops genetic and cell-free deoxyribonucleic acid (cfDNA) testing solutions. The company’s products include Signatera, a personalized ctDNA (circulating tumor DNA) blood test to assess MRD (molecular residual disease) and its recurrence; Aletra, a tissue-based genomic profiling test to identify genomic alterations and oncology biomarkers in a tumor; Prospera, a transplant rejection test to evaluate the risk of rejection of a transplanted kidney. It also offers Renasight test to detect genetic cause of kidney diseases; Horizon carrier screening test; Panorama non-invasive prenatal screening test; Empower hereditary cancer test; Vistara prenatal single gene screening test; Anora miscarriage test; and Spectrum preimplantation genetic test. Natera is headquartered in Austin, Texas, the US.

Headquarters United States of America

Address 13011 Mccallen Pass, Building A Suite 100, Austin, Texas, 78753


Telephone 1 650 2499090

No of Employees 2,670

Industry Medical Equipment

Ticker Symbol & Exchange NTRA (NASD)

Revenue (2021) $625.5M 60% (2021 vs 2020)

EPS XXX

Net Income (2021) XXX -105.3% (2021 vs 2020)

Market Cap* $3.4B

Net Profit Margin (2021) XXX -28.4% (2021 vs 2020)

* As of and is in US$

Explore premium data & analytics

70+

Medical Clinical Trials

A database of clinical trials planned, currently ongoing, completed, suspended, withdrawn, and terminated in countries around the world.

20+

Lead Sheet

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for Natera Inc’s relevant decision makers and contact details.

20+

Medical Pipeline Products

A database of medical devices that are in the process to get approved for sale around the world. Devices that are in development, through to those in the approval process are included.

14+

Medical Marketed Products

A database of medical devices currently for sale around the world. Devices that have been approved by a regulatory authority are included.

12+

Clinical Trials

Determine Natera Inc go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

2

Investigators

Review investigator profiles and find information on trial contacts across Natera Inc, including performance indicators like number of completed trials, and linked attributes such as rehiring statistics.

Subscribe to Company Analytics & gain access to premium industry data & analytics Subscribe to Company Analytics & gain access to premium industry data & analytics Start Here

Products and Services

Products Brands
Signatera: natera
Circulating Tumor DNA Blood Test Signatera
Aletra: Prospera
XXX XXX
XXX XXX
XXX XXX
Subscribe to Company Analytics for access to more products & services data Subscribe to Company Analytics for access to more products & services data Learn More

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2022 Others In January, the company anounced its expansion into the early cancer detection (ECD) market to advance the company’s strategic growth objectives.
2021 New Products/Services In June, the company and BGI Genomics announced to launch BGI/Natera Signatera Assay for biopharmaceutical customers and clinicians across China.
2021 New Product Approvals In June, the company secured ADLT status from the Centers for Medicare & Medicaid Services for the Signatera molecular residual disease test.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Get Started
Image for loader

Competitor Comparison

Key Parameters Natera Inc Roche Diagnostics International Ltd Exact Sciences Corp Guardant Health Inc Adaptive Biotechnologies Corp
Headquarters United States of America Switzerland United States of America United States of America United States of America
City Austin Rotkreuz Madison Redwood City Seattle
State/Province Texas Zug Wisconsin California Washington
No. of Employees 2,670 2,600 6,420 1,373 858
Entity Type Public Private Public Public Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more

Key Financial Charts

Operating Margin
Operating Margin
EPS (Earnings per Share)
EPS (Earnings per Share)
Debt to Equity Ratio
Debt to Equity Ratio
Return on Assets
Return on Assets
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Find out more
Executives
Name Position Board Since Age
Matthew Rabinowitz, Ph.D. Chairman Executive Board 2019 48
Steve Chapman Chief Executive Officer; President; Director Executive Board 2019 42
Michael Brophy Chief Financial Officer Senior Management 2017 41
Robert Schueren Chief Operating Officer Senior Management 2019 58
Renee Genovese Senior Director-Training Senior Management - -
Non Dignissim Eros Proin vel Convallis 2022 XX
Non Dignissim Eros Proin vel Convallis 2022 XX
Non Dignissim Eros Proin vel Convallis 2022 XX
Gain more insight into company management & employee structure with Company Analytics Gain more insight into company management & employee structure with Company Analytics Subscribe
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer